AAHRPP Revises Accreditation Standards
The Association for the Accreditation of Human Research Protection Programs, or AAHRPP as it's known, has issued a final version of its first major revisions to its standards, which are now eight years old. The process began in late 2008 and included a comprehensive review of the standards as well as a period for public comment. The result is a reduction in standards, from 22 to 15, and a reduction in the number of elements, from 77 to 60.
An AAHRPP press release describes the revisions as "providing a more logical framework for a human research protection program (HRPP) and better definition of the primary roles and responsibilities of the entities that comprise an HRPP."
It also says that the revised version allows for more flexibility in interpreting the standards and strengthens the standards on global research, conflict of interest, community-based research, and data and safety monitoring.
Starting March 1, 2010, organizations interested in applying for accredidation will follow the final revised accreditation standards, which will then be referred to as the AAHRPP Accreditation Standards. But from now until February 28, 2010, organizations may follow either the revised standards or the pre-revised accreditation standards.
Those interested in checking out the revised standards or comparing them with the current standards can do so at AAHRPP's Web site.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
